Single center study on clinical distribution and drug resistance analysis of <i>Staphylococcus aureus</i>

WANG Shanshan; XU Li; CHEN Zehui; LI Ling; LIU Yun

doi:10.7619/jcmp.20221457

Journal of Clinical Medicine in Practice > 2022 > 26(19): 83-86, 91. > DOI: 10.7619/jcmp.20221457

WANG Shanshan, XU Li, CHEN Zehui, LI Ling, LIU Yun. Single center study on clinical distribution and drug resistance analysis of Staphylococcus aureus[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 83-86, 91. DOI: 10.7619/jcmp.20221457

Citation:

PDF (1222 KB)

Single center study on clinical distribution and drug resistance analysis of Staphylococcus aureus

1.
Department of Laboratory, the First Affiliated Hospital of Naval Medical University of the Chinese People′s Liberation Army, Shanghai, 200433
2.
Department of Laboratory, Shidong Hospital of Yangpu District of Shanghai, Shanghai, 200438

More Information

Received Date: May 05, 2022
Available Online: October 23, 2022

Graphical Abstract

Abstract

Abstract

Objective
To analyze the clinical distribution characteristics and drug-resistant condition of Staphylococcus aureus (SA) in the First Affiliated Hospital of Naval Medical University of the Chinese People′s Liberation Army (called our hospital in the following text) from 2016 to 2020, so as to provide a basis for rational clinical application of antibacterial agents.
Methods
SA strains isolated from samples of 1 575 patients in our hospital from January 2016 to December 2020 were retrospectively analyzed. WHONET 5.6 software and SPSS software were used to statistically analyze the department distribution, sample source and drug resistance of the strains.
Results
A total of 1 784 strains were isolated from the samples, including 926 strains (51.9%) of methicillin resistant Staphylococcus aureus (MRSA). The highest detection rate of SA occurred in burn department (15.5%), followed by respiratory department (7.3%) and department of plastic surgery (5.9%). SA strains were mainly derived from respiratory tract samples (44.6%), followed by secretion (30.4%) and blood (5.6%). From year of 2016 to 2020, the resistance rate of SA to penicillin was more than 90%, resistance rates were more than 44.1% to 62.4%to erythromycin and clindamycin, and were more than 29.2% to 44.1%to tetracycline, ciprofloxacin, levofloxacin and moxifloxacin. The overall drug resistance rate of MRSA strains was generally higher than that of SA strains. No SA strains were found to be resistant to tigecycline, linezolid and vancomycin.
Conclusion
The detection rate of SA and MRSA in our hospital is high. Regular monitoring of their clinical distribution and drug resistance has high clinical value for the rational use of antibiotics and the prevention and control of nosocomial infection.
- Staphylococcus aureus,
- methicillin resistant Staphylococcus aureus,
- infection,
- clinical distribution,
- antibiotics,
- drug resistance

FullText(HTML)

References (16)

References

[1]	王大胜, 王大新, 耿平. 成人血流感染金黄色葡萄球菌的临床分布及耐药性分析[J]. 实用临床医药杂志, 2018, 22(1): 1-3. doi: 10.7619/jcmp.201801001
[2]	李敏燕, 王继红, 王吉刚, 等. 血液病住院患者血流感染病原菌分布及耐药性分析[J]. 临床军医杂志, 2021, 49(11): 1261-1263. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ202111027.htm
[3]	CHEUNG G Y C, BAE J S, OTTO M. Pathogenicity and virulence of Staphylococcus aureus[J]. Virulence, 2021, 12(1): 547-569. doi: 10.1080/21505594.2021.1878688
[4]	尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015: 120-123.
[5]	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[M]. 29th ed. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2019: 58-66.
[6]	SAKR A, BRÉGEON F, MÈGE J L, et al. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections[J]. Front Microbiol, 2018, 9: 2419. doi: 10.3389/fmicb.2018.02419
[7]	王红, 郁洁, 王博, 等. 住院新生儿鼻腔和体表定植金黄色葡萄球菌的分子特征及耐药性[J]. 中国循证儿科杂志, 2021, 16(5): 379-383. doi: 10.3969/j.issn.1673-5501.2021.05.010
[8]	武杰, 薛丽伟, 赵建平. 金黄色葡萄球菌血流感染111例的临床特征和预后[J]. 中国感染与化疗杂志, 2021, 21(3): 264-270. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202103004.htm
[9]	HSU Y Y, WU D, HUNG C C, et al. Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: prevalence, molecular characteristics and associated factors with nasal carriage[J]. BMC Infect Dis, 2020, 20(1): 254. doi: 10.1186/s12879-020-04979-8
[10]	刘云, 黄晓春, 马炜, 等. 烧伤患者院内感染病原菌分布及耐药性分析[J]. 第二军医大学学报, 2019, 40(7): 710-715. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201907003.htm
[11]	LEE A S, DE LENCASTRE H, GARAU J, et al. Methicillin-resistant Staphylococcus aureus[J]. Nat Rev Dis Primers, 2018, 4: 18033. doi: 10.1038/nrdp.2018.33
[12]	HIRAMATSU K, KATAYAMA Y, MATSUO M, et al. Multi-drug-resistant Staphylococcus aureus and future chemotherapy[J]. J Infect Chemother, 2014, 20(10): 593-601. doi: 10.1016/j.jiac.2014.08.001
[13]	全国细菌耐药监测网. MRSA甲氧西林耐药金黄色葡萄球菌检出率[EB/OL]. (2021-11-18)[2022-05-03]. http://www.carss.cn/sys/Htmls/dist/index.html#/resistance..
[14]	全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年胆汁细菌耐药监测报告[J]. 中国感染控制杂志, 2021, 20(1): 76-84. https://www.cnki.com.cn/Article/CJFDTOTAL-GRKZ202101008.htm
[15]	夏照帆, 肖仕初, 葛绳德. 海军军医大学第一附属医院烧伤外科60年发展历程回顾[J]. 中华烧伤杂志, 2018, 34(11): 741-743.
[16]	MCGUINNESS W A, MALACHOWA N, DELEO F R. Vancomycin resistance in Staphylococcus aureus[J]. Yale J Biol Med, 2017, 90(2): 269-281.

[1]	HOU Panfei, YU Jiufeng, ZHOU Suqin. Drug resistance and efflux pump gene in Acinetobacter baumannii in department of geriatrics[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 26-28. DOI: 10.7619/jcmp.20213771
[2]	FENG Liru, ZHAO Qing. Analysis of bacterial spectrum and drug resistance changes in children with infectious diarrhea in Shanxi Children′s Hospital from 2014 to 2019[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 45-48, 53. DOI: 10.7619/jcmp.20211991
[3]	ZHANG Hanqing, LIU Ying, FANG Xiao. Research on drug resistance of aneuploid colon cancer cells to cisplatin[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 42-45. DOI: 10.7619/jcmp.202001011
[4]	CHANG Huan. Clinical characteristics and drug resistance of Klebsiella pneumonia[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 12-15. DOI: 10.7619/jcmp.201907004
[5]	ZHANG Tingjun. Analysis of drug resistance and related intervention countermeasures in retreated pulmonary tuberculosis patients with severe pneumonia[J]. Journal of Clinical Medicine in Practice, 2018, (5): 45-48. DOI: 10.7619/jcmp.201805014
[6]	WANG Dasheng, WANG Daxin, GENG Ping. Clinical distribution and drug resistance of staphylococcus aureus bacteremia in adults with blood infection[J]. Journal of Clinical Medicine in Practice, 2018, (1): 1-3. DOI: 10.7619/jcmp.201801001
[7]	ZHENG Shenjian. Analysis of bacterial distribution and drug resistance in community acquired pneumonia of children under 5 years old in Xiaogan area[J]. Journal of Clinical Medicine in Practice, 2015, (11): 70-73,84. DOI: 10.7619/jcmp.201511021
[8]	ZHANG Keliang, LIU Erping, JIANG Yuqing. Detection and drug resistance analysis of mycoplasma infection in 9 029 female genital infection[J]. Journal of Clinical Medicine in Practice, 2013, (19): 163-164. DOI: 10.7619/jcmp.201319063
[9]	HE Chengchuan. Antibiotic resistance and antibiotic selection of klebsiella pneumoniae pneumonia: A study of 150 cases[J]. Journal of Clinical Medicine in Practice, 2013, (15): 85-86,89. DOI: 10.7619/jcmp.201315031
[10]	Analysis of distributing tendency and drug resistance of bacteria flora in nosocomial infection[J]. Journal of Clinical Medicine in Practice, 2013, (5): 111-114. DOI: 10.7619/jcmp.201305036

Cited By

Cited by

Periodical cited type(9)

1.	李国良，王海久，周虎，潘彪. 含雷替曲塞化疗方案的介入手术在中晚期肝细胞癌治疗中的研究进展. 实用药物与临床. 2025(01): 66-73 .
2.	熊日晖，袁国辉，赵新华. 柴胡化积汤联合经肝动脉化疗栓塞术在原发性肝癌姑息治疗中的应用效果观察. 中国当代医药. 2024(03): 104-107+111 .
3.	李森，邓俊魁，胡欣. 表柔比星联合奥沙利铂经导管动脉栓塞化疗治疗中晚期原发性肝癌患者的临床疗效. 癌症进展. 2024(09): 1033-1036 .
4.	王明玉. 载药微球肝动脉化疗栓塞术与碘油肝动脉化疗栓塞术治疗不可切除肝癌的效果比较. 实用临床医学. 2024(03): 14-17 .
5.	王东彩，仝永方，韩珍珍. 原发性肝癌患者经肝动脉化疗栓塞术治疗后癌因性疲乏发生的影响因素及管理对策分析. 黑龙江医学. 2024(17): 2058-2061 .
6.	王花，黑悦，孙淼，孙延闯，韩娟，孙娟华. 贝伐珠单抗联合雷替曲塞治疗不可切除肝细胞癌的疗效及对不良反应和生存率影响. 实用医学杂志. 2024(21): 3061-3066 .
7.	胡钧文，杨清梅，华杨，李永敏. 雷替曲塞与氟尿嘧啶对不可切除肝癌患者的疗效观察. 河北医药. 2023(05): 715-718 .
8.	王洪伟，安萃萃，刘超，海青. 雷替曲塞联合顺铂在原发性肝癌肝动脉化疗栓塞术中的应用价值分析. 中外医疗. 2023(28): 60-63 .
9.	潘嫚，杨业勤. 奥沙利铂联合表柔比星治疗原发性肝癌的效果. 中国卫生标准管理. 2022(23): 119-122 .

Other cited types(1)

Get Citation

PDF

XML

Article views (259) PDF downloads (12) Cited by(10)

Turn off MathJax

Article Contents

Abstract

References

Single center study on clinical distribution and drug resistance analysis of Staphylococcus aureus